Product Portfolio

Developing new molecules and adding value to established agents

Approved Products

Click for Important Safety Information.

Products in development

We are working in partnership with medac GmbH on several products in the pre-clinical, phase I, and phase II stages.

candidate indication pre-clinical phase I/II trials pivotal trial Launch
Rasuvo™ (methotrexate) injection Autoimmune        
MPI-3501 Oncology    
MPI-2710 Hematology    
MPI-2720 Hematology    
MPI-2730 Hematology    
Rasuvo™ (methotrexate) injection
Autoimmune
 
Launch  
pivotal trial  
phase I/II trials  
pre-clinical  
 
MPI-3501
Oncology
 
Launch
pivotal trial
phase I/II trials  
pre-clinical  
 
MPI-2710
Hematology
 
Launch
pivotal trial
phase I/II trials  
pre-clinical  
 
MPI-2720
Hematology
 
Launch
pivotal trial
phase I/II trials  
pre-clinical  
 
MPI-2730
Hematology
 
Launch
pivotal trial
phase I/II trials  
pre-clinical